We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rotavirus Vaccination Likely to Be Cost Saving to Society in the United States.
- Authors
Newall, Anthony T; Leong, Robert Neil; Reyes, Josephine F; Curns, Aaron T; Rudd, Jessica; Tate, Jacqueline; Macartney, Kristine; Parashar, Umesh
- Abstract
Background Following the introduction of rotavirus immunization in 2006 in the United States, there were substantial declines in the domestic rotavirus disease burden. In this study, we assess the value for money achieved by the program in the decade following vaccine introduction. Methods We applied an age-specific, static, multicohort compartmental model to examine the impact and cost-effectiveness of the US rotavirus immunization program in children <5 years of age using healthcare utilization data from 2001 to 2015 inclusive. We calculated the incremental cost-effectiveness ratio (ICER) per quality-adjusted life year (QALY) gained from both a healthcare system and societal perspective. Results Declines in healthcare use associated with the rotavirus and acute gastroenteritis occurred from 2006 and continued to grow before stabilizing from 2010 through 2011. From 2011 to 2015, an estimated annual average of approximately 118 000 hospitalizations, 86 000 emergency department presentations, and 460 000 outpatient and physician office visits were prevented. From a societal perspective during this same period, the program was estimated to be cost saving in the base case model and in >90% of probabilistic sensitivity analysis simulations and from a healthcare system perspective >98% of simulations found an ICER below $100 000 per QALY gained. Conclusions After the program stabilized, we found the rotavirus immunization in the United States was likely to have been cost saving to society. The greater than expected healthcare and productivity savings reflect the success of the rotavirus immunization program in the United States.
- Subjects
UNITED States; MEDICAL care costs; GASTROENTERITIS; IMMUNIZATION; EVALUATION of human services programs; RETROVIRUS diseases; AGE distribution; ATTITUDE (Psychology); COST control; COMMUNITIES; MEDICAL personnel; GOVERNMENT programs; MEDICAL care use; ROTAVIRUS vaccines; COST effectiveness; LONGITUDINAL method; QUALITY-adjusted life years; PUBLIC opinion; CHILDREN
- Publication
Clinical Infectious Diseases, 2021, Vol 73, Issue 8, p1424
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciab442